Pay in 4 interest-free payments of $6.08 Learn more
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Frequently Asked Questions Can semaglutide directly cause anemia
April 1, 2026: More People Join Federal Litigation Over Side Effects from Zepbound and Other GLP-1 Drugs As of April 1, 2026, there are 3,546 pending claims in MDL 3094 ( IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation )
GLP-1s are changing obesity care but nutrition may be the silent side effect. As Jorge Urbina and colleagues highlight in a 2026 Clinical Obesity narrative review, GLP-1 receptor agonists (e.g., semaglutide, liraglutide, tirzepatide) can predispose some patients to micronutrient and nutritional deficienciesvia appetite suppression, delayed gastric emptying, and altered intake/absorption
Semaglutide exposure was similar for the groups with moderate renal impairment and normal renal function
It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, which works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying
US$ 24.93
US$ 27.34
US$ 29.76
